Multifactorial analysis of risk factors for reduced bone mineral density among postmenopausal women

Archives of Medical Science

Volumn 8, Issue 2, 2012, Pages 332-341

  Ba̧czyk, Grazyna ^a   Opala, Tomasz ^a   Kleka, Paweł ^b   Chuchracki, Marek ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b ADAM MICKIEWICZ UNIVERSITY   (Poland)

Author keywords

Bone mineral density; Multifactorial analysis; Osteopenia; Osteoporosis; Postmenopausal women

Indexed keywords

ALENDRONIC ACID; CALCIUM; COLLAGEN TYPE 1; ESTRADIOL; OSTEOCALCIN; VITAMIN D;

ADULT; ARTICLE; BODY MASS; BONE DENSITY; CONTROLLED STUDY; CORRELATIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMUR NECK; FEMUR NECK FRACTURE; HIP; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MULTIPLE REGRESSION; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; VERTEBRA FRACTURE; VITAMIN SUPPLEMENTATION;

EID: 84861464271     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2012.28562     Document Type: Article

References (30)

1. Riggs BL, Khosla S, Melton U. A unitary model for involutional osteoporosis: estrogen deficiency causes both types I and II osteoporosis in post-menopausal women and osteoporosis in post-menopausal women and contributes to bone 1055 in aging men. J Bone Miner Res 1998; 13: 763-73. (Pubitemid 28224192)
2. Johnston CC Jr, Slemenda CW. Changes in skeletal tissue during the aging process. Nutr Rev 1992; 50: 385-7. (Pubitemid 23056462)
3. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 1994; 4: 368-81.
4. Blake GM, Naeem M, Boutros M. Comparison of effective dose to children and adults from dual X-ray absor - ptiometry examinations. Bone 2006; 38: 935-42. (Pubitemid 44498584)
5. Kelly TL Sp, von Stetton E. Performance evaluation of a multi-detector DXA device. J Bone Miner Res 1991;6 Suppl 1: S168.
6. Genant HK, Wu CY, Yan Kuijk. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993; 8: 1137-48. (Pubitemid 23261108)
7. Saag KG, Geusens P. Progress in osteoporosis and fracture prevention: focus on postmenopausal women. Arthritis Res Therapy 2009; 11: 251.
8. Sebba AI, Emkeyb RD, Kohlesc JD, Sambrookd PN. Ibandronate dose response is associated with increases in bone mineral density and reductions in clinical fractures: results of a meta-analysis. Bone 2009; 4: 423-7.
9. Panico A, Lupolo GA, Marciello F, et al. Teriparatide vs. alendronate as a treatment for osteoporosis: changes in biochemical markers of bone turnover, BMD and quality of life. Med Sci Monit 2011; CR442-448.
10. Joakimsen RM, Fonnebo V, Magnus JH, Tollan A, Sogaard AJ. The Tromso study: body height, body mass index and fractures. Osteoporos Int 1998; 8: 436-42. (Pubitemid 28486711)
11. De Laet C, Kanis JA, Oden A, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 2005; 16: 1330-8. (Pubitemid 41532085)
12. Hannan MT, Felson DT, Dawson-Hughes B, et al. Risk factors for longitudinal bone loss in elderly men and women: The Framingham Osteoporosis Study. J Bone Miner Res 2000; 15: 710-20. (Pubitemid 30174025)
13. Cauley JA, Gutai JP, Kuller LH, Scott J, Nevitt MC. Black- White differences in serum sex hormones and bone mineral density. Am J Epidemiol 1994; 139: 1035-46. (Pubitemid 24156700)
14. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PW, Anderson JJ. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993; 29: 1141-6. (Pubitemid 23295455)
15. Fiorelli C, Cori F, Petilli M, et al. Functional estrogen receptors in a human pre-osteoclastic cell line. Proc Natl Acad Sci USA 1995; 92: 2672-6.
16. Pacifici R. Cytokines, estrogen and postmenopausal osteoporosis: the second decade. Endocrinology 1998; 139: 2659-61.
17. Rogers A, Eastell R. Circulating osteoprotegerin and receptor activator for nuclear for NF kappa B ligand (RANKL): clinical utility in metabolic bone disease. J Clin Edocrinol Metab 2005; 90: 151-4.
18. Kanis JA. Johnell O, Oden A, et al. FRAXTM and The Assessment of fracture probability in men and women from the UK. Osteoporos Int 2008; 19: 385-97.
19. Pluskiewicz W, Adamczyk P, Franek E, et al. Ten-year probability of osteoporotic fracture in 2012 Polish women assessed by FRAX and nomogram by Nguyen et al. -Conformity between methods and their clinical utility. Bone 2010; 46: 1661-7.
20. Diaz MN, O'Neill TW, Silman AJ. The influence of family history of hip fracture on the risk of vertebral deformity in men and women: The European Vertebral Osteoporosis study. Bone 1997; 20: 145-9. (Pubitemid 27087003)
21. Heaney RP. Calcium, dairy products and osteoporosis. J Am Coll Nutr 2000; 19: 83S-99S. (Pubitemid 30185343)
22. Lips P, Graafmans W, Ooms ME, Bezener PD, Bouter LM. Vitamin D supplementation and fracture incidence in elderly persons. A randomized placebo-controlled clinical trial. Ann Intern Med 1996; 124: 400-6. (Pubitemid 26065071)
23. Trivedi DP, Doli R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomized double blind controlled trial. Br Med J 2003; 326: 469-72. (Pubitemid 36269626)
24. Chapuy MC, Arlot MF, Duboeuf F. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992; 327: 1637-42.
25. Grant AM, Avenell A, Campbell MK; RECORD Trial Group. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium OR vitamin D, RECORD): a rando - mized placebo-controlled trial. Lancet 2005; 365: 1621-8. (Pubitemid 40693411)
26. Porthouse J, Cockayne S, King C, et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin C3) for prevention of fractures in primary care. Br Med J 2005; 330: 1003.
27. Rabenda V, Bruyere O, Reginster JY. Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression. Osteoporos Int 2011; 22: 893-901.
28. Yazici S, Korkmaz U, Erkan M, et al. The effect of breastfeeding duration on bone mineral density in postmeno - pausal Turkish women: a population-based study. Arch Med Sci 2011; 7: 486-92.
29. Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 1994; 79: 1693-700.
30. Sypniewska G, Sobańska I, Pater A, et al. Does serum osteoprotegerin level relate to fragility fracture in elderly women with low vitamin D status? Med Sci Monit 2010; 16: CR96-101.